In light of litifilimab recently receiving FDA Breakthrough Therapy Designation for CLE, we spoke with experts to discuss diagnostic and treatment gaps in disease management.
Late-breaking AMETHYST Part A study results to be presented, showing safety and efficacy of litifilimab in cutaneous lupus erythematosus (CLE) Litifilimab was recently granted Breakthrough Therapy ...
A 19-year-old Chinese woman with a history of systemic lupus erythematous (SLE) visits a rheumatology clinic. She is 24-weeks pregnant and reports ...
At the 2026 Oscars, comedian Conan O’Brien made a joke during a skit to open the show that negatively associated his appearance with make-up to having lupus. Using lupus as a punchline, especially ...
A patient developed granulomatosis with polyangiitis (GPA), a type of antineutrophil cytoplasmic antibody (ANCA)-associated vasculitis (AAV), following a long-standing history of systemic lupus ...
Endometriosis is a painful, debilitating condition affecting 10% of women worldwide. It occurs when tissue similar to the lining of the uterus (known as lesions) grows elsewhere in the body – usually ...
Researchers at The Institute show that botulinum toxin is an effective and safe option for treating severe finger lesions ...